Wang, Y., Edelmayer, R., Wetter, J., Salte, K., Gauvin, D., Leys, L., Paulsboe, S., Su, Z., Weinberg, I., Namovic, M., Gauld, S. B., Honore, P., Scott, V. E., McGaraughty, S. Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation. Scientific Reports. 2019; 9: 5310. doi:10.1038/s41598-019-41655-7
Read MoreRead, E. Qualification of cellular starting materials for cell-based therapies. Cell & Gene Therapy Insights 2019; 5(2), 177-196. doi: 10.18609/cgti.2019.021
Read MoreRead, E. Qualification of cellular starting materials for cell-based therapies. Cell & Gene Therapy Insights 2019; 5(2), 177-196. doi: 10.18609/cgti.2019.021
Read MoreClarke, D., Smith, D. Managing starting material stability to maximize manufacturing flexibility and downstream efficiency. Cell & Gene Therapy Insights 2019; 5(2), 303-314. doi: 10.18609/cgti.2019.033
Read MoreClarke, D., Smith, D. Managing starting material stability to maximize manufacturing flexibility and downstream efficiency. Cell & Gene Therapy Insights 2019; 5(2), 303-314. doi: 10.18609/cgti.2019.033
Read More
According to data provided by the Alliance for Regenerative Medicine, there are nearly 900 companies responsible for more than 1000 industry-sponsored clinical trials within regenerative medicine utilizing advanced therapeutics including cell, gene, and tissue engineered products. Maintaining oversight on these precious therapies, literally vein-to-vein, encompassing a multitude of stakeholders, lengthy timelines, across countries and continents…
Read MoreStroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832
Read MoreStroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832
Read More
Disease models facilitate understanding the pathogenesis of disease, identification and development of potential interventions and evaluation of new treatments. BioLife Solutions maintains an online, searchable, Evidence Library that contains over 365 articles, abstracts and posters citing Biopreservation efficacy of CryoStor® and HypoThermosol®. Recently added to the Evidence Library, the journal article authored by Xinyue Bai…
Read MoreHarrison, R., Lugo Leija, H. A., Strohbuecker, S., Crutchley, J., Marsh, S., Denning, C., El Haj, A., Sottile, V. Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing. Stem Cell Res Ther, 2018 Sept 26; 9(1):248. doi:10.1186/s13287-018-0968-0.
Read More